ORGANIGRAM GLOBAL INC
OGINASDAQTrading Snapshot
- Day Range
- $1.06 β $1.09
- 52-Week Range
- $0.85 β $2.24
- Volume
- $2.52B
- Avg Volume
- $2.58B
- Shares Outstanding
- 140.8M
- Next Earnings
- Dec 16, 2026
Fundamentals Snapshot
- Annual Revenue
- $186M
- Last Q Revenue
- $106M
- P/E Ratio
- 2.3
- P/S Ratio
- 0.7x
- EPS (TTM)
- $0.64
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +20.3%
Why Investors Own OGI
- βHigh-growth profile β revenue up +57.0% YoY with expanding US Equity exposure.
- βHealthy economics β 44% gross margin and 12% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
ORGANIGRAM GLOBAL INC
OGIAbout ORGANIGRAM GLOBAL INC
Organigram Global Inc., primarily operating through its subsidiary Organigram Holdings Inc., is a Canadian enterprise specializing in the cultivation, production, and distribution of cannabis and related products. The company serves the medical cannabis market by offering products such as cannabis flowers, oils, and vaporizing devices to both civilian patients and military veterans. For adult recreational consumers, Organigram provides a diverse range of cannabis products, including edibles and concentrates, under popular brands like Edison Cannabis Co., Trail Blazer, SHRED, SHRED'ems, Big Bag O' Buds, and Monjour. Additionally, the company acts as a wholesale supplier, distributing cannabis plant cuttings, dried flowers, proprietary blends, pre-rolled products, and various cannabis derivatives to retailers and other wholesalers within the adult-use recreational sector. Customers can purchase Organigram's offerings through its online platform or via telephone orders. Established in 2013, the company's corporate headquarters are located in Moncton, Canada.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Price Target
βLatest News & Updates

Reviewing Organigram Global (NASDAQ:OGI) & KORU Medical Systems (NASDAQ:KRMD)
KORU Medical Systems (NASDAQ: KRMD - Get Free Report) and Organigram Global (NASDAQ: OGI - Get Free Report) are both small-cap healthcare companies, but which is the better business? We will compare the two companies bas

Organigram Global to Host 2026 OG Investor Session
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI) (the "Company" or "Organigram"), Canada's #1 cannabis company by market share and a growing global cannabis platform, today announced details of i

Organigram Global Accelerates Integration of Sanity Group Under Unified Global Operating Structure
Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI) (Γ’ΒΒOrganigramΓ’ΒΒ or the Γ’ΒΒCompanyΓ’ΒΒ) today announced an important milestone in its global growth strategy thr

OrganiGram (OGI) Reports Q3 Loss, Beats Revenue Estimates
OrganiGram (OGI) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to a loss of $0.03 per share a year ago.

Organigram Global Q3 Earnings Call Highlights
Organigram Global NASDAQ: OGI reported record third-quarter fiscal 2026 revenue and adjusted EBITDA, aided by the consolidation of Germany-based Sanity Group and improving performance in several Canadian cannabis categor

Organigram Reports Record Third Quarter Fiscal 2026 Results
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the βCompanyβ or βOrganigramβ), Canada's #1 cannabis company by market share2 and a growing global cannabis platform following its acquisition o